|Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women|
QA Karim, SSA Karim, JA Frohlich, AC Grobler, C Baxter, LE Mansoor, ...
science 329 (5996), 1168-1174, 2010
|Timing of initiation of antiretroviral drugs during tuberculosis therapy|
SS Abdool Karim, K Naidoo, A Grobler, N Padayatchi, C Baxter, A Gray, ...
New England Journal of Medicine 362 (8), 697-706, 2010
|HIV/AIDS epidemiology, pathogenesis, prevention, and treatment|
V Simon, DD Ho, QA Karim
The Lancet 368 (9534), 489-504, 2006
|HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response|
SSA Karim, GJ Churchyard, QA Karim, SD Lawn
the Lancet 374 (9693), 921-933, 2009
|HIV infection and AIDS in sub-Saharan Africa: current status, challenges and opportunities|
ABM Kharsany, QA Karim
The open AIDS journal 10, 34, 2016
|Repurposed antiviral drugs for COVID-19—interim WHO SOLIDARITY trial results|
WHO Solidarity Trial Consortium
New England Journal of Medicine 384 (6), 497-511, 2021
|Achieving the health Millennium Development Goals for South Africa: challenges and priorities|
M Chopra, JE Lawn, D Sanders, P Barron, SSA Karim, D Bradshaw, ...
The Lancet 374 (9694), 1023-1031, 2009
|Adolescent girls and young women: key populations for HIV epidemic control|
RC Dellar, S Dlamini, QA Karim
Journal of the International AIDS Society 18, 19408, 2015
|Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape|
PL Moore, ES Gray, CK Wibmer, JN Bhiman, M Nonyane, DJ Sheward, ...
Nature medicine 18 (11), 1688-1692, 2012
|Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers.|
QA Karim, SS Karim, K Soldan, M Zondi
American journal of public health 85 (11), 1521-1525, 1995
|Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women|
NR Klatt, R Cheu, K Birse, AS Zevin, M Perner, L NoŽl-Romas, A Grobler, ...
Science 356 (6341), 938-945, 2017
|Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa|
A Reddi, SC Leeper, AC Grobler, R Geddes, KH France, GL Dorse, ...
BMC pediatrics 7 (1), 1-13, 2007
|Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women|
SSA Karim, ADM Kashuba, L Werner, QA Karim
The Lancet 378 (9787), 279-281, 2011
|Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression|
L Roberts, JAS Passmore, C Williamson, F Little, LM Bebell, K Mlisana, ...
AIDS (London, England) 24 (6), 819, 2010
|Informed consent for HIV testing in a South African hospital: is it truly informed and truly voluntary?|
Q Abdool Karim, SS Abdool Karim, HM Coovadia, M Susser
American journal of public health 88 (4), 637-640, 1998
|Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study|
F Van Loggerenberg, K Mlisana, C Williamson, SC Auld, L Morris, ...
PloS one 3 (4), e1954, 2008
|Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis|
CS Morrison, PL Chen, C Kwok, JM Baeten, J Brown, AM Crook, ...
PLoS Med 12 (1), e1001778, 2015
|Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study|
T De Oliveira, ABM Kharsany, T Gršf, C Cawood, D Khanyile, A Grobler, ...
The lancet HIV 4 (1), e41-e50, 2017
|Family planning: the essential link to achieving all eight Millennium Development Goals|
Contraception 81 (6), 460-461, 2010
|Preventing HIV infection in women: a global health imperative|
QA Karim, S Sibeko, C Baxter
Clinical Infectious Diseases 50 (Supplement_3), S122-S129, 2010